TCS has fired the starting gun. Now banking, pharma, and FMCG giants are up next. Here's your complete guide to navigating India's most important earnings season of the year.

Every quarter, India's corporate sector collectively holds up a mirror to the economy — and what stares back at us in the Q4 FY26 earnings season will be particularly revealing. After a year marked by geopolitical shocks, currency volatility, global trade disruptions, and a rollercoaster stock market, the March quarter results will tell us which businesses are truly resilient and which ones were merely riding a tide that has now turned.

With TCS having already set the tone and dozens of marquee names lining up to report, this is the most important four-week period for Indian equity investors in FY26. Let's break it all down.

TCS Sets the Tone: What Their Results Tell Us

Tata Consultancy Services, India's largest IT company and a bellwether for the entire tech sector, reported its Q4 FY26 results and delivered a mixed picture that perfectly encapsulates the dilemma facing Indian IT. Revenue grew 9.7% and net profit rose 12.2% for the March quarter — numbers that, in isolation, look healthy. However, the full-year picture revealed an annual revenue decline — the first in recent memory.

TCS management's commentary on AI is crucial: they stated that emerging AI tools have not reduced demand for their services. Whether this optimism proves justified will be one of the defining questions for the sector in FY27.

 Banking: The Sector That Will Make or Break the Season

Banking stocks are the single largest component of Nifty 50 and Sensex by weight. How banks report will disproportionately determine whether the recent market rally can sustain. India's banking sector enters Q4 from a position of relative strength — credit growth has been healthy, NPA ratios are near decadal lows, and capital adequacy remains robust.

The key variables to watch in banking results this quarter are: Net Interest Margin (NIM) compression as the RBI rate cut cycle begins, slippage trends in the retail and MSME loan books, and deposit growth in an environment where fixed deposit rates may have peaked.

Top Banking Names to Track

•         HDFC Bank: Post-merger integration progress and margin trajectory will be the primary focus.

•         ICICI Bank: Consistently the outperformer — watch for continued fee income growth and asset quality stability.

•         Axis Bank: A key recovery story; management commentary on slippage and credit cost will be critical.

•         SBI: Domestic loan growth and global book performance will be the headline numbers.

IT Sector: Reading Between the Lines

Beyond TCS, Infosys, Wipro, HCL Tech, and Tech Mahindra will all report in the coming weeks. The market will be watching for deal wins (Total Contract Value), demand recovery signals from BFSI and manufacturing verticals, and guidance for FY27.

The elephant in the room for IT is AI. Companies that can articulate a clear, credible AI monetisation strategy will likely command a premium. Those that sound defensive or vague about AI's impact on their business model could face de-rating pressure.

Pharma: Global Signals, Domestic Resilience

India's pharmaceutical sector is navigating a complex environment. Domestically, prescription drug growth remains healthy. However, the US generics business — the profit engine for major exporters — faces pricing pressure and potential policy risk from US drug pricing initiatives.

Sun Pharma is in the spotlight this quarter for its proposed $12 billion acquisition of US-based Organon & Co. If confirmed, this would be one of the largest M&A transactions in Indian pharma history. The market's reaction to any clarity on this deal will be worth watching closely.

FMCG: Rural Recovery in Focus

Consumer staples companies like HUL, Nestle, Marico, and Dabur will be reporting against the backdrop of a hoped-for rural demand recovery. After two years of urban consumption outpacing rural spending, early data suggests rural India may be catching up — thanks to better agricultural incomes, MGNREGS spending, and easing food inflation.

Investors in FMCG will be watching volume growth (not just value growth) as the true measure of health. Companies that can show volume growth above 5% will be rewarded. Those relying purely on price hikes to drive revenue will face scrutiny.

Auto: The EV Transition Accelerates

The automotive sector is at a fascinating inflection point. Traditional ICE vehicle sales remain strong, but the conversation has irrevocably shifted to EVs. Companies like M&M, Tata Motors, and Ola Electric will be watched for EV volume growth, margin trajectories, and capex guidance.

Hero MotoCorp, Bajaj Auto, and TVS Motor's performance in the two-wheeler segment will provide important clues about rural consumer health. Strong two-wheeler demand is often a leading indicator of broader rural revival.

How to Use Earnings Season as an Investor

The biggest mistake retail investors make during earnings season is reacting to individual quarterly results without context. A single bad quarter does not make a bad business. A single good quarter does not validate a stretched valuation.

Use earnings season to update your investment thesis on existing holdings. If a company reports results that fundamentally contradict the reasons you bought it, that is worth re-evaluating. If results are in line or better, stay the course.

Disclaimer:
This blog is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any financial instrument. Views expressed are based on publicly available information and market understanding at the time of writing and are subject to change. Readers should consult their financial advisor before making any investment decisions. Investments in markets are subject to risk.